Calprotectin as potential novel biomarker in myasthenia gravis

Calprotectin as potential novel biomarker in myasthenia gravis

Myasthenia gravis (MG) is the most common autoimmune disease affecting the neuromuscular junction by specific autoantibodies. The etiology of MG and its heterogeneity in clinical courses are poorly understood, although it was recently shown that gut microbial dysbiosis plays a critical role. Since l...

Full description

Bibliographic Details
Main Authors: Frauke Stascheit, Benjamin Hotter, Sarah Hoffmann, Siegfried Kohler, Sophie Lehnerer, Andreas Sputtek, Andreas Meisel
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Journal of Translational Autoimmunity
Subjects:
Myasthenia gravis
Calprotectin
Microbial dysbiosis
Biomarker
Disease severity
Online Access:http://www.sciencedirect.com/science/article/pii/S2589909021000319

Internet

http://www.sciencedirect.com/science/article/pii/S2589909021000319

Similar Items